Supportive Care During Pediatric Hematopoietic Stem Cell Transplantation : Prevention of Infections. A Report From Workshops on Supportive Care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Copyright © 2021 Ifversen, Meisel, Sedlacek, Kalwak, Sisinni, Hutt, Lehrnbecher, Balduzzi, Diesch, Jarisch, Güngör, Stein, Yaniv, Bonig, Kuhlen, Ansari, Nava, Dalle, Diaz-de-Heredia, Trigoso, Falkenberg, Hartmann, Deiana, Canesi, Broggi, Bertaina, Gibson, Krivan, Vettenranta, Matic, Buechner, Lawitschka, Peters, Yesilipek, Yalçin, Lucchini, Bakhtiar, Turkiewicz, Niinimäki, Wachowiak, Cesaro, Dalissier, Corbacioglu, Willasch and Bader..
Specific protocols define eligibility, conditioning, donor selection, graft composition and prophylaxis of graft vs. host disease for children and young adults undergoing hematopoietic stem cell transplant (HSCT). However, international protocols rarely, if ever, detail supportive care, including pharmaceutical infection prophylaxis, physical protection with face masks and cohort isolation or food restrictions. Supportive care suffers from a lack of scientific evidence and implementation of practices in the transplant centers brings extensive restrictions to the child's and family's daily life after HSCT. Therefore, the Board of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) held a series of dedicated workshops since 2017 with the aim of initiating the production of a set of minimal recommendations. The present paper describes the consensus reached within the field of infection prophylaxis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Frontiers in pediatrics - 9(2021) vom: 07., Seite 705179 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Allogeneic hematological stem cell transplantation |
|---|
| Anmerkungen: |
Date Revised 17.08.2021 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3389/fped.2021.705179 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329390708 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329390708 | ||
| 003 | DE-627 | ||
| 005 | 20231225205017.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fped.2021.705179 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1097.xml |
| 035 | |a (DE-627)NLM329390708 | ||
| 035 | |a (NLM)34395344 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ifversen, Marianne |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Supportive Care During Pediatric Hematopoietic Stem Cell Transplantation |b Prevention of Infections. A Report From Workshops on Supportive Care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.08.2021 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2021 Ifversen, Meisel, Sedlacek, Kalwak, Sisinni, Hutt, Lehrnbecher, Balduzzi, Diesch, Jarisch, Güngör, Stein, Yaniv, Bonig, Kuhlen, Ansari, Nava, Dalle, Diaz-de-Heredia, Trigoso, Falkenberg, Hartmann, Deiana, Canesi, Broggi, Bertaina, Gibson, Krivan, Vettenranta, Matic, Buechner, Lawitschka, Peters, Yesilipek, Yalçin, Lucchini, Bakhtiar, Turkiewicz, Niinimäki, Wachowiak, Cesaro, Dalissier, Corbacioglu, Willasch and Bader. | ||
| 520 | |a Specific protocols define eligibility, conditioning, donor selection, graft composition and prophylaxis of graft vs. host disease for children and young adults undergoing hematopoietic stem cell transplant (HSCT). However, international protocols rarely, if ever, detail supportive care, including pharmaceutical infection prophylaxis, physical protection with face masks and cohort isolation or food restrictions. Supportive care suffers from a lack of scientific evidence and implementation of practices in the transplant centers brings extensive restrictions to the child's and family's daily life after HSCT. Therefore, the Board of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) held a series of dedicated workshops since 2017 with the aim of initiating the production of a set of minimal recommendations. The present paper describes the consensus reached within the field of infection prophylaxis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a allogeneic hematological stem cell transplantation | |
| 650 | 4 | |a antibiotic prophylactic therapy | |
| 650 | 4 | |a children | |
| 650 | 4 | |a infection precaution | |
| 650 | 4 | |a vaccination | |
| 700 | 1 | |a Meisel, Roland |e verfasserin |4 aut | |
| 700 | 1 | |a Sedlacek, Petr |e verfasserin |4 aut | |
| 700 | 1 | |a Kalwak, Krzysztof |e verfasserin |4 aut | |
| 700 | 1 | |a Sisinni, Luisa |e verfasserin |4 aut | |
| 700 | 1 | |a Hutt, Daphna |e verfasserin |4 aut | |
| 700 | 1 | |a Lehrnbecher, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Balduzzi, Adriana |e verfasserin |4 aut | |
| 700 | 1 | |a Diesch, Tamara |e verfasserin |4 aut | |
| 700 | 1 | |a Jarisch, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Güngör, Tayfun |e verfasserin |4 aut | |
| 700 | 1 | |a Stein, Jerry |e verfasserin |4 aut | |
| 700 | 1 | |a Yaniv, Isaac |e verfasserin |4 aut | |
| 700 | 1 | |a Bonig, Halvard |e verfasserin |4 aut | |
| 700 | 1 | |a Kuhlen, Michaela |e verfasserin |4 aut | |
| 700 | 1 | |a Ansari, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Nava, Tiago |e verfasserin |4 aut | |
| 700 | 1 | |a Dalle, Jean-Hugues |e verfasserin |4 aut | |
| 700 | 1 | |a Diaz-de-Heredia, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Trigoso, Eugenia |e verfasserin |4 aut | |
| 700 | 1 | |a Falkenberg, Ulrike |e verfasserin |4 aut | |
| 700 | 1 | |a Hartmann, Mihaela |e verfasserin |4 aut | |
| 700 | 1 | |a Deiana, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Canesi, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Broggi, Chiara |e verfasserin |4 aut | |
| 700 | 1 | |a Bertaina, Alice |e verfasserin |4 aut | |
| 700 | 1 | |a Gibson, Brenda |e verfasserin |4 aut | |
| 700 | 1 | |a Krivan, Gergely |e verfasserin |4 aut | |
| 700 | 1 | |a Vettenranta, Kim |e verfasserin |4 aut | |
| 700 | 1 | |a Matic, Toni |e verfasserin |4 aut | |
| 700 | 1 | |a Buechner, Jochen |e verfasserin |4 aut | |
| 700 | 1 | |a Lawitschka, Anita |e verfasserin |4 aut | |
| 700 | 1 | |a Peters, Christina |e verfasserin |4 aut | |
| 700 | 1 | |a Yesilipek, Akif |e verfasserin |4 aut | |
| 700 | 1 | |a Yalçin, Koray |e verfasserin |4 aut | |
| 700 | 1 | |a Lucchini, Giovanna |e verfasserin |4 aut | |
| 700 | 1 | |a Bakhtiar, Shahrzad |e verfasserin |4 aut | |
| 700 | 1 | |a Turkiewicz, Dominik |e verfasserin |4 aut | |
| 700 | 1 | |a Niinimäki, Riitta |e verfasserin |4 aut | |
| 700 | 1 | |a Wachowiak, Jacek |e verfasserin |4 aut | |
| 700 | 1 | |a Cesaro, Simone |e verfasserin |4 aut | |
| 700 | 1 | |a Dalissier, Arnaud |e verfasserin |4 aut | |
| 700 | 1 | |a Corbacioglu, Selim |e verfasserin |4 aut | |
| 700 | 1 | |a Willasch, Andre Manfred |e verfasserin |4 aut | |
| 700 | 1 | |a Bader, Peter |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in pediatrics |d 2013 |g 9(2021) vom: 07., Seite 705179 |w (DE-627)NLM234254327 |x 2296-2360 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2021 |g day:07 |g pages:705179 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fped.2021.705179 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2021 |b 07 |h 705179 | ||